Literature DB >> 28673895

Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines.

Eleanor L Woodward1, Andrea Biloglav1, Naveen Ravi1, Minjun Yang1, Lars Ekblad2, Johan Wennerberg3, Kajsa Paulsson1.   

Abstract

Entities:  

Year:  2017        PMID： 28673895     DOI： 10.1530/ERC-16-0522e

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  3 in total

1.  Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology.

Authors:  Ana T Pinto; Marta Pojo; Joana Simões-Pereira; Ruben Roque; Ana Saramago; Lúcia Roque; Carmo Martins; Saudade André; José Cabeçadas; Valeriano Leite; Branca M Cavaco
Journal:  Endocrine       Date:  2019-07-31       Impact factor: 3.633

2.  A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.

Authors:  Ying C Henderson; Abdallah S R Mohamed; Anastasios Maniakas; Yunyun Chen; Reid T Powell; Shaohua Peng; Maria Cardenas; Michelle D Williams; Diana Bell; Mark E Zafereo; Rui Jennifer Wang; Steve E Scherer; David A Wheeler; Maria E Cabanillas; Marie-Claude Hofmann; Faye M Johnson; Clifford C Stephan; Vlad Sandulache; Stephen Y Lai
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

3.  Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling.

Authors:  Yina Liao; Yao Gao; An Chang; Zongjuan Li; Huayu Wang; Jing Cao; Wei Gu; Ranran Tang
Journal:  J Cell Mol Med       Date:  2020-09-15       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.